ロード中...
Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy
Within the past decade, there has been a revolution in the types of drugs developed to treat cancer. Therapies that selectively target cancer-specific aberrations, such as kinase inhibitors, have made a dramatic impact on a subset of patients. In spite of these successes, there is still a dearth of...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3637405/ https://ncbi.nlm.nih.gov/pubmed/23151129 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|